Veru Inc (VERU) Stock Price, Quote & News

Company Profile

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle l...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 509 6897

Website: verupharma.com

Address:

2916 North Miami Avenue, Suite 1000, Miami, United States

mrkymrk Feb. 4 at 3:01 PM

$NVO Novo missed out on the home run in Metaera. What they need to do is start hitting singles and doubles. Waiting for the next home run is costing them BILLIONS!!! $VERU is just one example of a complimentary oral drug that could help with differentiation in older populations.

0 · Reply

Eesnimi Feb. 4 at 8:02 AM

$VERU $VERU I am interested in proxy contest or any other kind of joining the forces of shareholders ! Together we can do a lot. I am from EU and at the moment seems that i can not even vote against their new scamming attempts. This is the biggest loss of my life and i am more than willing to do something about it. Company needs to be SOLD but they are paying themselves 1 million salaries and diluting and gifting themselves more shares!

1 · Reply

mrkymrk Feb. 3 at 5:54 PM

$VERU Novo struggling and can’t compete in a competitive landscape. And yet there is a possibility of partnering with or acquiring VE RU to have the ONLY ORAL lean mass preserving combo on the planet and VERU management still can’t make the case. WEAK!!!!!!!

0 · Reply

mrkymrk Feb. 2 at 9:10 PM

$VERU typical POS

0 · Reply

Joecoon12 Feb. 2 at 3:19 PM

$VERU 🔥🔥🔥🔥

0 · Reply

Sttst219 Feb. 1 at 11:27 PM

$VERU Search Harry Fisch if you are looking to go down a strange and fascinating rabbit hole https://www.justice.gov/epstein

1 · Reply

Eesnimi Jan. 30 at 9:26 AM

$VERU These scammers want to dilute again? I guess all of the investors here are voting against it!? I can not even register at Proxyvote from outside of US! What partnership with NVO are you talking about? Source?

1 · Reply

mrkymrk Jan. 29 at 6:02 PM

$VERU signs partnership with $NVO already!! WTF

1 · Reply

WallStreetBuyDip Jan. 29 at 12:48 PM

How do you trade small and mid cap stocks? I buy when H% is low. Nothing else. I keep track of my results to see if my strategy worked out or not. $BBIG + $VERU will trade the same.

0 · Reply

Truthseeker7856 Jan. 28 at 10:44 PM

$VERU "The Internet and telephone voting, will close at 11:59 p.m. (Eastern Time) , pn March 11, 2026. Please be aware That if you vote over the internet or by telephone, you may incur costs such as telephone or internet access for which might be responsible." 😆 LOL

0 · Reply

Veru Inc. (VERU) Q4 2025 Earnings Call Transcript

Dec 17, 2025, 6:30 AM EST - 7 weeks ago

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

Dec 10, 2025, 8:30 AM EST - 2 months ago

Veru to Report Fiscal Year 2025 Financial Results on December 17th

Oct 31, 2025, 8:30 AM EDT - 3 months ago

Veru to Present Two Abstracts at ObesityWeek 2025

Oct 29, 2025, 4:01 PM EDT - 3 months ago

Veru Announces Proposed Public Offering

Sep 23, 2025, 8:30 AM EDT - 4 months ago

Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity

Aug 12, 2025, 12:57 PM EDT - 6 months ago

Veru Inc. (VERU) Q3 2025 Earnings Call Transcript

Aug 12, 2025, 6:30 AM EDT - 6 months ago

Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress

Aug 11, 2025, 8:30 AM EDT - 6 months ago

Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study

Aug 6, 2025, 8:30 AM EDT - 6 months ago

Veru Announces Reverse Stock Split

Jul 22, 2025, 8:30 AM EDT - 7 months ago

Veru to Participate in the 2025 BTIG Virtual Biotech Conference

Jun 11, 2025, 8:30 AM EDT - 8 months ago

Veru to Participate in the Virtual BTIG Obesity Health Forum

May 28, 2025, 12:11 PM EDT - 9 months ago

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

May 28, 2025, 6:30 AM EDT - 9 months ago

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

May 26, 2025, 9:36 PM EDT - 9 months ago

Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom

May 8, 2025, 12:42 PM EDT - 9 months ago

Veru Inc. (VERU) Q2 2025 Earnings Call Transcript

May 8, 2025, 9:30 AM EDT - 9 months ago

JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level

May 8, 2025, 9:25 AM EDT - 9 months ago

Veru Participates in a Virtual Investor KOL Connect Segment

May 8, 2025, 6:30 AM EDT - 9 months ago

Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress

May 1, 2025, 8:30 AM EDT - 9 months ago

Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8

Apr 16, 2025, 8:30 AM EDT - 10 months ago

Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit

Mar 31, 2025, 8:30 AM EDT - 11 months ago

Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference

Feb 19, 2025, 10:41 AM EST - 1 year ago

Fat, not muscle: Drugmakers in race for next weight-loss breakthrough

ARWR AZN BHVN KROS LLY NVO REGN

Feb 13, 2025, 2:35 PM EST - 1 year ago

Veru Inc (VERU) Q1 2025 Earnings Call Transcript

Feb 13, 2025, 6:30 AM EST - 1 year ago

Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress

Jan 27, 2025, 10:34 AM EST - 1 year ago

Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough

Jan 27, 2025, 6:30 AM EST - 1 year ago

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction

Dec 31, 2024, 8:30 AM EST - 1 year ago

Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business

Nov 26, 2024, 8:30 AM EST - 1 year ago

Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders

Nov 5, 2024, 8:30 AM EST - 1 year ago

Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek

Oct 21, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss

Oct 16, 2024, 8:30 AM EDT - 1 year ago

Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress

Sep 11, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the 2024 Cantor Global Healthcare Conference

Aug 10, 2024, 8:39 AM EDT - 1 year ago

Veru Inc. (VERU) Q3 2024 Earnings Call Transcript

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024

Jul 29, 2024, 8:30 AM EDT - 1 year ago

Veru to Participate in the BTIG Virtual Biotechnology Conference

Jul 2, 2024, 8:30 AM EDT - 1 year ago

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

Jun 24, 2024, 8:30 AM EDT - 1 year ago

Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions

Jun 18, 2024, 4:05 PM EDT - 1 year ago

Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024

Jun 17, 2024, 4:45 PM EDT - 1 year ago

Veru Reminds Shareholders to Vote in Advance of Tomorrow's Deadline for 2024 Annual Meeting of Shareholders

Jun 10, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the American Diabetes Association's 84th Scientific Sessions

May 22, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the Jefferies Global Healthcare Conference

May 15, 2024, 8:30 AM EDT - 1 year ago

Veru Announces Steven B. Heymsfield M.D.

May 14, 2024, 8:30 AM EDT - 1 year ago

Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week

May 8, 2024, 6:30 AM EDT - 1 year ago

Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program

May 2, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the GLP-1 Based Therapeutics Summit

May 1, 2024, 8:30 AM EDT - 1 year ago

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

Apr 30, 2024, 8:30 AM EDT - 1 year ago

Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Apr 25, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11

mrkymrk Feb. 4 at 3:01 PM

0 · Reply

Eesnimi Feb. 4 at 8:02 AM

1 · Reply

mrkymrk Feb. 3 at 5:54 PM

0 · Reply

mrkymrk Feb. 2 at 9:10 PM

$VERU typical POS

0 · Reply

Joecoon12 Feb. 2 at 3:19 PM

$VERU 🔥🔥🔥🔥

0 · Reply

Sttst219 Feb. 1 at 11:27 PM

$VERU Search Harry Fisch if you are looking to go down a strange and fascinating rabbit hole https://www.justice.gov/epstein

1 · Reply

Eesnimi Jan. 30 at 9:26 AM

1 · Reply

mrkymrk Jan. 29 at 6:02 PM

$VERU signs partnership with $NVO already!! WTF

1 · Reply

WallStreetBuyDip Jan. 29 at 12:48 PM

How do you trade small and mid cap stocks? I buy when H% is low. Nothing else. I keep track of my results to see if my strategy worked out or not. $BBIG + $VERU will trade the same.

0 · Reply

Truthseeker7856 Jan. 28 at 10:44 PM

0 · Reply

Eesnimi Jan. 28 at 5:01 AM

$VERU Reminder to newbies. Under $10 - complete garbage and would not even be allowed to trade without the reverse split. 10-20 shows slight uptrend. 30-50 arriving to normality. 3 years ago price was over $200. Stock has lost 90%+ of the value. Arriving to any kind of normality from here needs over 1000%

1 · Reply

Geraldgenofranco1953 Jan. 28 at 1:09 AM

$VERU About to run?

0 · Reply

mrkymrk Jan. 27 at 10:01 PM

$VERU the are conducting trial with oral semiglutide. That’s thinking ahead but very disappointing this didn’t result in a partnership. This management simply can’t get it done. They are weak.

1 · Reply

RealInvestorActivists Jan. 27 at 8:20 PM

$VERU There are many biotech things doing such things as per AI to artificially just list their stock, shareholders are like bread for them as per

1 · Reply

Divad22 Jan. 27 at 3:45 PM

$VERU Presentation update on its website.

0 · Reply

mrkymrk Jan. 23 at 12:28 PM

$VERU Novos weekly script data for the pill is booming! An increase of 5x to 20k scripts. This should bode extremely well for VERU because it emphasizes people wants pills over injections. If companies want lean muscle preservation differentiation for their GLP going forward, VERU is the ONLY ORAL drug being studied. At this low of market cap and I can only blame our shitty management for not getting a deal done.

1 · Reply

mrkymrk Jan. 22 at 2:48 PM

$VERU why do I feel like $NVO is about to do a deal with them. These 2 stocks have been moving in lock step together over the past 2 weeks. Would make sense based on new oral GLP pill and the need to not only differentiate from competitors but to have a solution that holds on to the dearly beloved lean muscle. Maybe just desperate and wishful thinking …

1 · Reply

BioRich Jan. 21 at 8:14 PM

$ALT The Phase 3 you should be watching more closely than the money drain with Pemvi is $LXRX. I think @scoobydoo16 is high on that one, along with $VERU maybe it was one of the two Bobby's (@Hatrak1 or @MAG2TROL). Anyway, worth a look. Less stress and bigger gain potential.

1 · Reply

WallStreetBuyDip Jan. 20 at 7:48 AM

How do you trade small and mid cap stocks? I buy when H% is low. Nothing else. I keep track of my results to see if my strategy worked out or not. $BBIG + $VERU will trade the same.

0 · Reply

Patrick_Squarepants Jan. 20 at 2:21 AM

$VERO What can I say, but good luck tomorrow longs. When I wake up in the morning and check out the premarket on Benzinga, once, for once, I hope to see $VERU on the left (green) side indicating a DAY 2 continuation. Alas, it probably won't happen (and more likely appear on the other side), but good luck and take care!

0 · Reply

Eesnimi Jan. 17 at 6:49 AM

$VERU 10% done. Now needs only +990% more to arrive to normality

1 · Reply

Scrapps64 Jan. 16 at 11:00 PM

$VERU Why did this pos jump today?

1 · Reply

Market Cap	40.61M
Revenue (ttm)	0.00
Net Income (ttm)	-22.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	42,906
Avg Vol	157,842
Day's Range	N/A - N/A
Shares Out	16.05M
Stochastic %K	23%
Beta	-1.42
Analysts	Sell
Price Target	$18.00